
Jennifer Sue Pitrak Mcdonald
Examiner (ID: 18643, Phone: (571)270-3061 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1609, 3796, 3792, 1635, 1674 |
| Total Applications | 600 |
| Issued Applications | 220 |
| Pending Applications | 26 |
| Abandoned Applications | 355 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5210965
[patent_doc_number] => 20070249549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Compounds and Methods for Rna Interference of the P65 Subunit of Nf-Kappa-B'
[patent_app_type] => utility
[patent_app_number] => 10/582946
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9594
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249549.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582946 | Compounds and Methods for Rna Interference of the P65 Subunit of Nf-Kappa-B | Dec 16, 2004 | Abandoned |
Array
(
[id] => 6983851
[patent_doc_number] => 20050153921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Methods of using mammalian RNase H and compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 11/001386
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16264
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153921.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001386
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001386 | Methods of using mammalian RNase H and compositions thereof | Nov 30, 2004 | Abandoned |
Array
(
[id] => 5738058
[patent_doc_number] => 20060008448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Inhibition of li expression in mammalian cells'
[patent_app_type] => utility
[patent_app_number] => 10/999208
[patent_app_country] => US
[patent_app_date] => 2004-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 26753
[patent_no_of_claims] => 159
[patent_no_of_ind_claims] => 147
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20060008448.pdf
[firstpage_image] =>[orig_patent_app_number] => 10999208
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/999208 | Inhibition of li expression in mammalian cells | Nov 28, 2004 | Abandoned |
Array
(
[id] => 9389348
[patent_doc_number] => 08685946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Sequence-specific inhibition of small RNA function'
[patent_app_type] => utility
[patent_app_number] => 10/998364
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 37
[patent_no_of_words] => 30710
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10998364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/998364 | Sequence-specific inhibition of small RNA function | Nov 25, 2004 | Issued |
Array
(
[id] => 4970719
[patent_doc_number] => 20070110721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Plasmid maintenance'
[patent_app_type] => utility
[patent_app_number] => 10/579981
[patent_app_country] => US
[patent_app_date] => 2004-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10044
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20070110721.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579981
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579981 | Plasmid maintenance | Nov 21, 2004 | Issued |
Array
(
[id] => 5188408
[patent_doc_number] => 20070166716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Method for evaluating rnai activity and mirna activity'
[patent_app_type] => utility
[patent_app_number] => 10/579906
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13360
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166716.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579906
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579906 | Method for evaluating rnai activity and mirna activity | Nov 17, 2004 | Abandoned |
Array
(
[id] => 7050704
[patent_doc_number] => 20050186591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Method of treating neurodegenerative disease'
[patent_app_type] => utility
[patent_app_number] => 10/991286
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 59217
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186591.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991286
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991286 | Method of treating neurodegenerative disease | Nov 16, 2004 | Abandoned |
Array
(
[id] => 6925847
[patent_doc_number] => 20050239102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Nucleic acid binding oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/977990
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16439
[patent_no_of_claims] => 127
[patent_no_of_ind_claims] => 68
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239102.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977990 | Nucleic acid binding oligonucleotides | Oct 28, 2004 | Abandoned |
Array
(
[id] => 7075267
[patent_doc_number] => 20050148535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'IAP nucleobase oligomers and oligomeric complexes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/975974
[patent_app_country] => US
[patent_app_date] => 2004-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20285
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148535.pdf
[firstpage_image] =>[orig_patent_app_number] => 10975974
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/975974 | IAP nucleobase oligomers and oligomeric complexes and uses thereof | Oct 27, 2004 | Abandoned |
Array
(
[id] => 5739038
[patent_doc_number] => 20060009429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Antiandrogen oligonucleotides usable for the treatment of dermatological androgen-related disorders relating to androgen metabolism, their pharmaceutical compositions, their uses and treatment method'
[patent_app_type] => utility
[patent_app_number] => 10/948781
[patent_app_country] => US
[patent_app_date] => 2004-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 9497
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009429.pdf
[firstpage_image] =>[orig_patent_app_number] => 10948781
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/948781 | Antiandrogen oligonucleotides usable for the treatment of dermatological androgen-related disorders relating to androgen metabolism, their pharmaceutical compositions, their uses and treatment method | Sep 22, 2004 | Abandoned |
Array
(
[id] => 7075265
[patent_doc_number] => 20050148533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Modulation of RANKL expression'
[patent_app_type] => utility
[patent_app_number] => 10/944274
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29651
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10944274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/944274 | Modulation of RANKL expression | Sep 16, 2004 | Issued |
Array
(
[id] => 5004997
[patent_doc_number] => 20070202567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Diagnostics And Therapeutics For Diseases Associated With Arginyl Aminopeptidase Rnpep (Rnpep)'
[patent_app_type] => utility
[patent_app_number] => 10/573584
[patent_app_country] => US
[patent_app_date] => 2004-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 32936
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573584 | Diagnostics And Therapeutics For Diseases Associated With Arginyl Aminopeptidase Rnpep (Rnpep) | Sep 15, 2004 | Abandoned |
Array
(
[id] => 5183495
[patent_doc_number] => 20070054849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Method for diagnosing hepatocellular carcinomas'
[patent_app_type] => utility
[patent_app_number] => 10/572932
[patent_app_country] => US
[patent_app_date] => 2004-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16086
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054849.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572932
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572932 | Method for diagnosing hepatocellular carcinomas | Sep 13, 2004 | Abandoned |
Array
(
[id] => 5189079
[patent_doc_number] => 20070167388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Nucleotide sequences promoting the trans-membrane transport of nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 10/571412
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4697
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167388.pdf
[firstpage_image] =>[orig_patent_app_number] => 10571412
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/571412 | Nucleotide sequences promoting the trans-membrane transport of nucleic acids | Sep 9, 2004 | Abandoned |
Array
(
[id] => 7026614
[patent_doc_number] => 20050020529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Delivery construct for antisense nucleic acids and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/927934
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8548
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020529.pdf
[firstpage_image] =>[orig_patent_app_number] => 10927934
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/927934 | Delivery construct for antisense nucleic acids and methods of use | Aug 26, 2004 | Abandoned |
Array
(
[id] => 6990896
[patent_doc_number] => 20050089933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Compositions and methods for surrogate antibody modulation of an immune response and transport'
[patent_app_type] => utility
[patent_app_number] => 10/912448
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 34666
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089933.pdf
[firstpage_image] =>[orig_patent_app_number] => 10912448
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/912448 | Compositions and methods for surrogate antibody modulation of an immune response and transport | Aug 4, 2004 | Abandoned |
Array
(
[id] => 7050699
[patent_doc_number] => 20050186586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Methods and compositions for enhancing the efficacy and specificity of RNAi'
[patent_app_type] => utility
[patent_app_number] => 10/912440
[patent_app_country] => US
[patent_app_date] => 2004-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 44404
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186586.pdf
[firstpage_image] =>[orig_patent_app_number] => 10912440
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/912440 | Methods and compositions for enhancing the efficacy and specificity of RNA silencing | Aug 3, 2004 | Issued |
Array
(
[id] => 5642270
[patent_doc_number] => 20060280725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Compositions and methods of treating and diagnosing hepatoma'
[patent_app_type] => utility
[patent_app_number] => 10/563339
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 20466
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20060280725.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563339
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563339 | Compositions and methods of treating and diagnosing hepatoma | Jun 29, 2004 | Abandoned |
Array
(
[id] => 7005727
[patent_doc_number] => 20050171040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 10/864044
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 56957
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171040.pdf
[firstpage_image] =>[orig_patent_app_number] => 10864044
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/864044 | RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA) | Jun 8, 2004 | Abandoned |
Array
(
[id] => 7019291
[patent_doc_number] => 20050221310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Methods for enhancing gene expression analysis'
[patent_app_type] => utility
[patent_app_number] => 10/504072
[patent_app_country] => US
[patent_app_date] => 2004-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14276
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221310.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504072
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504072 | Methods for enhancing gene expression analysis | Jun 3, 2004 | Abandoned |